Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients

NCT00780702 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00780702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00780702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 1
Overall status
Completed
Start date
May 8, 2008
Completion date
April 16, 2013
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence, cocaine-related disorders, opioid-related disorders